Biography
- Total Career Publications: 100 https://orcid.org/0000-0001-5433-8398
- h-index: 39 https://scholar.google.com/citations?user=2PFzkdUAAAAJ&hl=en
- Total Career Research Income: €1,579,728 (PI (€235,644) & co-PI/collaborator ( €1,344,000))
- Research Income (2008-2014): €1,534,728
Research Interests
My Research interests can be broken down into three broad and overlapping themes.- Factors influencing design and performance of pharmaceutical dosage forms
- Formulation technology: novel approaches to enhance oral drug delivery
- In vitro, in-silico and in vivo models for predicting Bioavailability and pharmacokinetics in humans
My related Research Objectives, which translate from these research interests are:
- Oral Drug Delivery - Novel Formulation approaches to enhance bioavailability
- Colonic Drug Delivery - Design and assessment of colonic release dosage forms
- Brain Drug Delivery - Strategies to enhance drug delivery to the brain
Research Grants
| Project | Funding Body | Start Date | End Date | Award | |
|---|---|---|---|---|---|
| Development of novel Lipid based solid dispersion (LBSD) formulations for enhancing and bioavailability | Enterprise Irl | 10-MAY-10 | 24-JUN-11 | €96,544.00 | |
| Systematic evaluation of the bioavailability and therapeutic efficacy of a novel lipid based formulation of lycopene for use in the chemoprevention of prostate cancer | Other: Not Listed | 01-OCT-06 | 01-OCT-09 | €110,249.00 | |
| Addressing the problem of variable food effect bioavailability for emerging new drug candidates: how to predict and how to produce. | Irish Research Council | 01-OCT-18 | 31-JAN-22 | €102,125.00 | |
| Food for Health Ireland (FHI) - Appetite Modulation | Enterprise Ireland | 01-OCT-14 | 30-SEP-16 | €371,011.00 | |
| Biodegradable microparticles for drug delivery | Tyndall National Institute National Access Programme | 01-OCT-08 | 01-OCT-09 | €36,600.00 | |
| Pharmaceutical Education and Research with Regulatory Links: Innovative Drug Development Strategies and Regulatory Tools Tailored to Fcailitate Earlier Access to Medicines. | Horizon 2020 | 01-MAY-16 | 31-AUG-20 | €531,349.00 | |
| Drug loaded nanoparticles produced using Microfluidics: precise control of size, shape and surface characteristics of single ‘Lab-on-Chip’ device | Tyndall National Institute National Access Programme | 01-OCT-11 | 01-OCT-12 | €18,000.00 | |
| Investigation of the effect of Bumetanide on NKCC1 and development of strategies to enhance Bumetanide delivery to the brain in neonatal seizures. | Irish Research Council | 01-DEC-12 | 30-NOV-15 | €72,000.00 |
Publications
Peer Reviewed Journals
| Year | Publication | |
|---|---|---|
| (2024) | 'Exploring career choices of pharmacy graduates over 15 years: A cross-sectional evaluation' Fitzpatrick KL; Allen EA; Griffin BT; O'Shea JP; Dalton K; Bennett-Lenane H (2024) 'Exploring career choices of pharmacy graduates over 15 years: A cross-sectional evaluation'. Currents in Pharmacy Teaching and Learning, [DOI] [Details] | |
| (2023) | 'Advancing Algorithmic Drug Product Development: Recommendations for Machine Learning Approaches in Drug Formulation' Murray JD;Lange JJ;Bennett-Lenane H;Holm R;Kuentz M;O'Dwyer PJ;Griffin BT; (2023) 'Advancing Algorithmic Drug Product Development: Recommendations for Machine Learning Approaches in Drug Formulation'. European Journal of Pharmaceutical Sciences, [DOI] [Details] | |
| (2023) | 'Leveraging the use of in vitro and computational methods to support the development of enabling oral drug products: An InPharma commentary' Reppas C;Kuentz M;Bauer-Brandl A;Carlert S;Dallmann A;Dietrich S;Dressman J;Ejskjaer L;Frechen S;Guidetti M;Holm R;Holzem FL;Karlsson ¿;Kostewicz E;Panbachi S;Paulus F;Senniksen MB;Stillhart C;Turner DB;Vertzoni M;Vrenken P;Zöller L;Griffin BT;O'Dwyer PJ; (2023) 'Leveraging the use of in vitro and computational methods to support the development of enabling oral drug products: An InPharma commentary'. European Journal of Pharmaceutical Sciences, 188 [DOI] [Details] | |
| (2022) | 'Gut microbiota-drug interactions in cancer pharmacotherapies: implications for efficacy and adverse effects' Leigh, Sarah-Jane; Lynch, Caoimhe M. K.; Healey Bird, Brian R.; Griffin, Brendan T.; Cryan, John F.; Clarke, Gerard (2022) 'Gut microbiota-drug interactions in cancer pharmacotherapies: implications for efficacy and adverse effects'. Expert Opinion On Drug Metabolism & Toxicology, [DOI] [Full Text] [Details] | |
| (2022) | 'Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series' McAllister, M;Flanagan, T;Cole, S;Abend, A;Kotzagiorgis, E;Limberg, J;Mead, H;Mangas-Sanjuan, V;Dickinson, PA;Moir, A;Pepin, X;Zhou, DS;Tistaert, C;Dokoumetzidis, A;Anand, O;Le Merdy, M;Turner, DB;Griffin, BT;Darwich, A;Dressman, J;Mackie, C (2022) 'Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series'. Pharmaceutics, 14 [DOI] [Details] | |
| (2022) | 'Lipophilic Salts and Lipid-Based Formulations for Bridging the Food Effect Gap of Venetoclax' Koehl, NJ;Henze, LJ;Holm, R;Kuentz, M;Keating, JJ;De Vijlder, T;Marx, A;Griffin, BT (2022) 'Lipophilic Salts and Lipid-Based Formulations for Bridging the Food Effect Gap of Venetoclax'. Journal of Pharmaceutical Sciences, 111 :164-174 [DOI] [Details] | |
| (2022) | 'P-glycoprotein-mediated transport in a mucus-supplemented Caco-2 cell model in the presence of different surfactants' Jakobsen, S;Ge, LG;Pedersen, M;Griffin, BT;Holm, R;Nielsen, CU (2022) 'P-glycoprotein-mediated transport in a mucus-supplemented Caco-2 cell model in the presence of different surfactants'. International Journal of Pharmaceutics, 624 [DOI] [Details] | |
| (2022) | 'Best practices in current models mimicking drug permeability in the gastrointestinal tract - an UNGAP review' O'Shea JP;Augustijns P;Brandl M;Brayden DJ;Brouwers J;Griffin BT;Holm R;Jacobsen AC;Lennernäs H;Vinarov Z;O'Driscoll CM; (2022) 'Best practices in current models mimicking drug permeability in the gastrointestinal tract - an UNGAP review'. European Journal of Pharmaceutical Sciences, 170 :106098-106133 [DOI] [Details] | |
| (2021) | 'Artificial neural networks to predict the apparent degree of supersaturation in supersaturated lipid-based formulations: A pilot study' Bennett-Lenane, Harriet; O'Shea, Joseph P.; Murray, Jack D.; Ilie, Alexandra-Roxana; Holm, René; Kuentz, Martin; Griffin, Brendan T. (2021) 'Artificial neural networks to predict the apparent degree of supersaturation in supersaturated lipid-based formulations: A pilot study'. Pharmaceutics, 13 (9):1-14 [DOI] [Full Text] [Details] | |
| (2021) | 'Characterization of gastrointestinal transit and luminal conditions in pigs using a telemetric motility capsule' Henze, Laura J.; Koehl, Niklas J.; Bennett-Lenane, Harriet; Holm, René; Grimm, Michael; Schneider, Felix; Weitschies, Werner; Koziolek, Mirko; Griffin, Brendan T. (2021) 'Characterization of gastrointestinal transit and luminal conditions in pigs using a telemetric motility capsule'. European Journal of Pharmaceutical Sciences, 156 [DOI] [Full Text] [Details] | |
| (2021) | 'Oral biopharmaceutics tools: recent progress from partnership through the Pharmaceutical Education and Research with Regulatory Links collaboration' O'Dwyer PJ;Box KJ;Dressman J;Griffin BT;Henze LJ;Litou C;Pentafragka C;Statelova M;Vertzoni M;Reppas C; (2021) 'Oral biopharmaceutics tools: recent progress from partnership through the Pharmaceutical Education and Research with Regulatory Links collaboration'. Journal of Pharmacy and Pharmacology, 73 (4) [DOI] [Details] | |
| (2021) | 'Exploring precipitation inhibitors to improve in vivo absorption of cinnarizine from supersaturated lipid-based drug delivery systems' Ilie, AR;Griffin, BT;Vertzoni, M;Kuentz, M;Kolakovic, R;Prudic-Paus, A;Malash, A;Bohets, H;Herman, J;Holm, R (2021) 'Exploring precipitation inhibitors to improve in vivo absorption of cinnarizine from supersaturated lipid-based drug delivery systems'. European Journal of Pharmaceutical Sciences, 159 [DOI] [Details] | |
| (2021) | 'In Silico, In Vitro, and In Vivo Evaluation of Precipitation Inhibitors in Supersaturated Lipid-Based Formulations of Venetoclax' Koehl NJ;Henze LJ;Bennett-Lenane H;Faisal W;Price DJ;Holm R;Kuentz M;Griffin BT; (2021) 'In Silico, In Vitro, and In Vivo Evaluation of Precipitation Inhibitors in Supersaturated Lipid-Based Formulations of Venetoclax'. Molecular Pharmaceutics, 18 (6) [DOI] [Full Text] [Details] | |
| (2021) | 'The gut microbiome influences the bioavailability of olanzapine in rats' Cussotto, Sofia; Walsh, Jacinta; Golubeva, Anna V.; Zhdanov, Alexander V.; Strain, Conall R.; Fouhy, Fiona; Stanton, Catherine; Dinan, Timothy G.; Hyland, Niall P.; Clarke, Gerard; Cryan, John F.; Griffin, Brendan T. (2021) 'The gut microbiome influences the bioavailability of olanzapine in rats'. Ebiomedicine, 66 [DOI] [Full Text] [Details] | |
| (2021) | 'Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network' Vinarov Z;Abrahamsson B;Artursson P;Batchelor H;Berben P;Bernkop-Schnürch A;Butler J;Ceulemans J;Davies N;Dupont D;Flaten GE;Fotaki N;Griffin BT;Jannin V;Keemink J;Kesisoglou F;Koziolek M;Kuentz M;Mackie A;Meléndez-Martínez AJ;McAllister M;Müllertz A;O'Driscoll CM;Parrott N;Paszkowska J;Pavek P;Porter CJH;Reppas C;Stillhart C;Sugano K;Toader E;Valentová K;Vertzoni M;De Wildt SN;Wilson CG;Augustijns P; (2021) 'Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network'. Advanced Drug Delivery Reviews, 171 [DOI] [Details] | |
| (2021) | 'Machine learning methods for prediction of food effects on bioavailability: A comparison of support vector machines and artificial neural networks' Bennett-Lenane, Harriet; Griffin, Brendan T.; O'Shea, Joseph P. (2021) 'Machine learning methods for prediction of food effects on bioavailability: A comparison of support vector machines and artificial neural networks'. European Journal of Pharmaceutical Sciences, [DOI] [Full Text] [Details] | |
| (2021) | 'Exploring porcine gastric and intestinal fluids using microscopic and solubility estimates: Impact of placebo self-emulsifying drug delivery system administration to inform bio-predictive in vitro tools' Bennett-Lenane, Harriet; Jørgensen, Jacob R.; Koehl, Niklas J.; Henze, Laura J.; O'Shea, Joseph P.; Müllertz, Anette; Griffin, Brendan T. (2021) 'Exploring porcine gastric and intestinal fluids using microscopic and solubility estimates: Impact of placebo self-emulsifying drug delivery system administration to inform bio-predictive in vitro tools'. European Journal of Pharmaceutical Sciences, 161 [DOI] [Full Text] [Details] | |
| (2021) | 'Synthesis and In Vivo Evaluation of Insulin-Loaded Whey Beads as an Oral Peptide Delivery System' Heade, J;McCartney, F;Chenlo, M;Marro, OM;Severic, M;Kent, R;Bleiel, SB;Alvarez, CV;Griffin, BT;Brayden, DJ (2021) 'Synthesis and In Vivo Evaluation of Insulin-Loaded Whey Beads as an Oral Peptide Delivery System'. Pharmaceutics, 13 [DOI] [Details] | |
| (2021) | 'Combining species specific in vitro & in silico models to predict in vivo food effect in a preclinical stage – case study of Venetoclax' Henze, Laura J.; Koehl, Niklas J.; O'Shea, Joseph P.; Holm, René; Vertzoni, Maria; Griffin, Brendan T. (2021) 'Combining species specific in vitro & in silico models to predict in vivo food effect in a preclinical stage – case study of Venetoclax'. European Journal of Pharmaceutical Sciences, 162 [DOI] [Full Text] [Details] | |
| (2021) | 'Rational Selection of Bio-Enabling Oral Drug Formulations-A PEARRL Commentary' Kuentz, M;Holm, R;Kronseder, C;Saal, C;Griffin, BT (2021) 'Rational Selection of Bio-Enabling Oral Drug Formulations-A PEARRL Commentary'. Journal of Pharmaceutical Sciences, 110 :1921-1930 [DOI] [Details] | |
| (2020) | 'Chase dosing of lipid formulations to enhance oral bioavailability of nilotinib in rats' Koehl, Niklas J.; Holm, Rene; Kuentz, Martin; Griffin, Brendan T. (2020) 'Chase dosing of lipid formulations to enhance oral bioavailability of nilotinib in rats'. Pharmaceutical Research, 37 (7) [DOI] [Full Text] [Details] | |
| (2020) | 'Exploring the impact of surfactant type and digestion: Highly digestible surfactants improve oral bioavailability of nilotinib' Koehl, Niklas J.; Holm, René; Kuentz, Martin; Jannin, Vincent; Griffin, Brendan T. (2020) 'Exploring the impact of surfactant type and digestion: Highly digestible surfactants improve oral bioavailability of nilotinib'. Molecular Pharmaceutics, 17 (9):3202-3213 [DOI] [Full Text] [Details] | |
| (2020) | 'Toward simplified oral lipid-based drug delivery using mono-/di-glycerides as single component excipients' Ilie, AR;Griffin, BT;Vertzoni, M;Kuentz, M;Cuyckens, F;Wuyts, K;Kolakovic, R;Holm, R (2020) 'Toward simplified oral lipid-based drug delivery using mono-/di-glycerides as single component excipients'. Drug Development and Industrial Pharmacy, [DOI] [Details] | |
| (2020) | 'Applying computational predictions of biorelevant solubility ratio upon self-emulsifying lipid-based formulations dispersion to predict dose number' Bennett-Lenane, Harriet; Koehl, Niklas J.; O'Dwyer, Patrick J.; Box, Karl J.; O'Shea, Joseph P.; Griffin, Brendan T. (2020) 'Applying computational predictions of biorelevant solubility ratio upon self-emulsifying lipid-based formulations dispersion to predict dose number'. Journal of Pharmaceutical Sciences, [DOI] [Full Text] [Details] | |
| (2020) | 'Toward simplified oral lipid-based drug delivery using mono-/di-glycerides as single component excipients' Ilie, Alexandra-Roxana; Griffin, Brendan T.; Vertzoni, Maria; Kuentz, Martin; Cuyckens, Filip; Wuyts, Koen; Kolakovic, Ruzica; Holm, René (2020) 'Toward simplified oral lipid-based drug delivery using mono-/di-glycerides as single component excipients'. Drug Development and Industrial Pharmacy, :1-10 [DOI] [Full Text] [Details] | |
| (2020) | 'Perspectives of Pharmacists on Facilitating Experiential Learning Placements for Pharmacy Students in Non Patient Facing Settings' Donovan MD, Byrne EM, Griffin BT. (2020) 'Perspectives of Pharmacists on Facilitating Experiential Learning Placements for Pharmacy Students in Non Patient Facing Settings'. Currents in Pharmacy Teaching and Learning, [DOI] [Full Text] [Details] | |
| (2020) | 'Exploring impact of supersaturated lipid-based drug delivery systems of celecoxib on in vitro permeation across PermeapadⓇ membrane and in vivo absorption' Ilie, Alexandra-Roxana; Griffin, Brendan T.; Brandl, Martin; Bauer-Brandl, Annette; Jacobsen, Ann-Christin; Vertzoni, Maria; Kuentz, Martin; Kolakovic, Ruzica; Holm, René (2020) 'Exploring impact of supersaturated lipid-based drug delivery systems of celecoxib on in vitro permeation across PermeapadⓇ membrane and in vivo absorption'. European Journal of Pharmaceutical Sciences, 152 [DOI] [Full Text] [Details] | |
| (2020) | 'Development and evaluation of a biorelevant medium simulating porcine gastrointestinal fluids' Henze, Laura J.; Koehl, Niklas J.; Jansen, Regina; Holm, René; Vertzoni, Maria; Whitfield, Phil D.; Griffin, Brendan T. (2020) 'Development and evaluation of a biorelevant medium simulating porcine gastrointestinal fluids'. European Journal Of Pharmaceutics And Biopharmaceutics, 154 :116-126 [DOI] [Full Text] [Details] | |
| (2020) | 'Supersaturated lipid-based drug delivery systems – exploring impact of lipid composition type and drug properties on supersaturability and physical stability' Ilie, Alexandra-Roxana; Griffin, Brendan T.; Kolakovic, Ruzica; Vertzoni, Maria; Kuentz, Martin; Holm, René (2020) 'Supersaturated lipid-based drug delivery systems – exploring impact of lipid composition type and drug properties on supersaturability and physical stability'. Drug Development and Industrial Pharmacy, :1-29 [DOI] [Full Text] [Details] | |
| (2020) | 'Gut microbiome-mediated modulation of hepatic cytochrome P450 and P-glycoprotein: impact of butyrate and fructo-oligosaccharide-inulin' Walsh, Jacinta; Gheorghe, Cassandra E.; Lyte, Joshua M.;van de Wouw, Marcel; Boehme, Marcus; Dinan, Timothy G.; Cryan, John F.; Griffin, Brendan T.; Clarke, Gerard; Hyland, Niall P. (2020) 'Gut microbiome-mediated modulation of hepatic cytochrome P450 and P-glycoprotein: impact of butyrate and fructo-oligosaccharide-inulin'. Journal of Pharmacy and Pharmacology, [DOI] [Full Text] [Details] | |
| (2020) | 'Novel Biphasic Lipolysis Method To Predict in Vivo Performance of Lipid-Based Formulations' O'Dwyer PJ;Box KJ;Koehl NJ;Bennett-Lenane H;Reppas C;Holm R;Kuentz M;Griffin BT; (2020) 'Novel Biphasic Lipolysis Method To Predict in Vivo Performance of Lipid-Based Formulations'. Molecular Pharmaceutics, [DOI] [Full Text] [Details] | |
| (2020) | 'A retrospective biopharmaceutical analysis of >800 approved oral drug products: Are drug properties of solid dispersions and lipid-based formulations distinctive?' Bennett-Lenane, Harriet;O'Shea, Joseph P.;O'Driscoll, Caitriona M.;Griffin, Brendan T. (2020) 'A retrospective biopharmaceutical analysis of >800 approved oral drug products: Are drug properties of solid dispersions and lipid-based formulations distinctive?'. Journal of Pharmaceutical Sciences, [DOI] [Full Text] [Details] | |
| (2020) | 'Impact of host and environmental factors on ß-glucuronidase enzymatic activity: implications for gastrointestinal serotonin' Walsh, Jacinta; Olavarria-Ramirez, Loreto; Lach, Gilliard; Boehme, Marcus; Dinan, Timothy G.; Cryan, John F.; Griffin, Brendan T.; Hyland, Niall P.; Clarke, Gerard (2020) 'Impact of host and environmental factors on ß-glucuronidase enzymatic activity: implications for gastrointestinal serotonin'. American Journal of Physiology - Gastrointestinal and Liver Physiology, [DOI] [Full Text] [Details] | |
| (2020) | 'Supersaturated lipid-based formulations to enhance the oral bioavailability of venetoclax' Koehl, Niklas J.; Henze, Laura J.; Kuentz, Martin; Holm, René; Griffin, Brendan T. (2020) 'Supersaturated lipid-based formulations to enhance the oral bioavailability of venetoclax'. Pharmaceutics, 12 (6):1-20 [DOI] [Full Text] [Details] | |
| (2019) | 'Gut Reactions: Breaking Down Xenobiotic-Microbiome Interactions' Clarke G;Sandhu KV;Griffin BT;Dinan TG;Cryan JF;Hyland NP; (2019) 'Gut Reactions: Breaking Down Xenobiotic-Microbiome Interactions'. Pharmacological reviews, 71 (2) [DOI] [Full Text] [Details] | |
| (2019) | 'The pig as a preclinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms: a PEARRL review' Henze, Laura J.; Koehl, Niklas J.; O'Shea, Joseph P.; Kostewicz, Edmund S.; Holm, René; Griffin, Brendan T. (2019) 'The pig as a preclinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms: a PEARRL review'. Journal of Pharmacy and Pharmacology, [Details] | |
| (2019) | 'Toward the establishment of a standardized pre-clinical porcine model to predict food effects - case studies on Fenofibrate and Paracetamol' Henze, Laura J.; Koehl, Niklas J.; O'Shea, Joseph P.; Holm, René; Vertzoni, Maria; Griffin, Brendan T. (2019) 'Toward the establishment of a standardized pre-clinical porcine model to predict food effects - case studies on Fenofibrate and Paracetamol'. International Journal Of Pharmaceutics: X, [DOI] [Full Text] [Details] | |
| (2019) | 'New Insights into Using Lipid Based Suspensions for "Brick Dust' Molecules: Case Study of Nilotinib' Koehl, NJ;Holm, R;Kuentz, M;Griffin, BT (2019) 'New Insights into Using Lipid Based Suspensions for "Brick Dust' Molecules: Case Study of Nilotinib'. Pharmaceutical Research, 36 [DOI] [Details] | |
| (2019) | 'The PEARRL reviews – innovative drug development strategies tailored to facilitate earlier access to new oral medicines [Editorial]' Griffin, Brendan T.; Dressman, Jennifer B. (2019) 'The PEARRL reviews – innovative drug development strategies tailored to facilitate earlier access to new oral medicines [Editorial]'. Journal of Pharmacy and Pharmacology, 71 (4):439-440 [DOI] [Full Text] [Details] | |
| (2019) | 'Food for thought: formulating away the food effect - a PEARRL review' O'Shea JP;Holm R;O'Driscoll CM;Griffin BT; (2019) 'Food for thought: formulating away the food effect - a PEARRL review'. Journal of Pharmacy and Pharmacology, 71 (4) [DOI] [Full Text] [Details] | |
| (2018) | 'Lipophilicity and hydrophobicity considerations in bio-enabling oral formulations approaches – a PEARRL review' Ditzinger, F. and Price, D.J. and Ilie, A.-R. and Köhl, N.J. and Jankovic, S. and Tsakiridou, G. and Aleandri, S. and Kalantzi, L. and Holm, R. and Nair, A. and Saal, C. and Griffin, B. and Kuentz, M. (2018) 'Lipophilicity and hydrophobicity considerations in bio-enabling oral formulations approaches – a PEARRL review'. Journal of Pharmacy and Pharmacology, [DOI] [Details] | |
| (2016) | 'Effect of P-Glycoprotein Inhibition on the Brain Distribution and Antidepressant-Like Activity of Escitalopram in Rodents' O'Brien, FE;O'Connor, RM;Clarke, G;Dinan, TG;Griffin, BT;Cryan, JF (2016) 'Effect of P-Glycoprotein Inhibition on the Brain Distribution and Antidepressant-Like Activity of Escitalopram in Rodents'. IRISH JOURNAL OF MEDICAL SCIENCE, 185 :36-36 [Details] | |
| (2016) | 'Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives' Donovan, Maria D.; Griffin, Brendan T.; Kharoshankaya, Liudmila; Cryan, John F.; Boylan, Geraldine B. (2016) 'Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives'. Drugs, 76 :647-661 [DOI] [Full Text] [Details] | |
| (2016) | 'Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel' Cushen, SJ;Power, DG;Murphy, KP;McDermott, R;Griffin, BT;Lim, M;Daly, L;MacEneaney, P;Sullivan, KO;Prado, CM;Ryan, AM (2016) 'Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel'. Clinical Nutrition Espen, 13 :39-45 [DOI] [Details] | |
| (2016) | 'Effect of P-Glycoprotein Inhibition on the Brain Distribution and Antidepressant-Like Activity of Escitalopram in Rodents' O'Brien, FE,O'Connor, RM,Clarke, G,Dinan, TG,Griffin, BT,Cryan, JF (2016) 'Effect of P-Glycoprotein Inhibition on the Brain Distribution and Antidepressant-Like Activity of Escitalopram in Rodents'. Irish journal of medical science, 185 :36-36 [Details] | |
| (2016) | 'In vitro bidirectional permeability studies identify pharmacokinetic limitations of NKCC1 inhibitor bumetanide' Donovan, MD;Schellekens, H;Boylan, GB;Cryan, JE;Griffin, BT (2016) 'In vitro bidirectional permeability studies identify pharmacokinetic limitations of NKCC1 inhibitor bumetanide'. European Journal of Pharmacology, 770 :117-125 [DOI] [Details] | |
| (2016) | 'The Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome' Enright EF;Gahan CG;Joyce SA;Griffin BT; (2016) 'The Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome'. The Yale journal of biology and medicine, 89 (3) [Details] | |
| (2015) | 'The effect of organic anion transporter 3 inhibitor probenecid on bumetanide levels in the brain: an integrated in vivo microdialysis study in the rat' Donovan, MD;O'Brien, FE;Boylan, GB;Cryan, JF;Griffin, BT (2015) 'The effect of organic anion transporter 3 inhibitor probenecid on bumetanide levels in the brain: an integrated in vivo microdialysis study in the rat'. Journal of Pharmacy and Pharmacology, 67 :501-510 [DOI] [Details] | |
| (2015) | 'Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments' O'Shea, JP;Faisal, W;Ruane-O'Hora, T;Devine, KJ;Kostewicz, ES;O'Driscoll, CM;Griffin, BT (2015) 'Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments'. European Journal Of Pharmaceutics And Biopharmaceutics, 96 :207-216 [DOI] [Details] | |
| (2015) | 'Exploring the Impact of Drug Properties on the Extent of Intestinal Lymphatic Transport - In Vitro and In Vivo Studies' Lawless, E;Griffin, BT;O'Mahony, A;O'Driscoll, CM (2015) 'Exploring the Impact of Drug Properties on the Extent of Intestinal Lymphatic Transport - In Vitro and In Vivo Studies'. Pharmaceutical Research, 32 :1817-1829 [DOI] [Details] | |
| (2015) | 'Chronic P-glycoprotein inhibition increases the brain concentration of escitalopram: potential implications for treating depression' O'Brien, FE;Moloney, GM;Scott, KA;O'Connor, RM;Clarke, G;Dinan, TG;Griffin, BT;Cryan, JF (2015) 'Chronic P-glycoprotein inhibition increases the brain concentration of escitalopram: potential implications for treating depression'. Pharmacology Research &Amp; Perspectives, 3 [DOI] [Details] | |
| (2014) | 'Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles' Keohane, K;Brennan, D;Galvin, P;Griffin, BT (2014) 'Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles'. International Journal of Pharmaceutics, 467 :60-69 [DOI] [Details] | |
| (2014) | 'The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram' O'Brien, FE;O'Connor, RM;Clarke, G;Donovan, MD;Dinan, TG;Griffin, BT;Cryan, JF (2014) 'The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram'. Behavioural Brain Research, 261 :17-25 [DOI] [Details] | |
| (2014) | 'PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene glycol length and nanoparticle stability' Godinho BM;Ogier JR;Quinlan A;Darcy R;Griffin BT;Cryan JF;O'Driscoll CM; (2014) 'PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene glycol length and nanoparticle stability'. International Journal of Pharmaceutics, 473 (1-2) [DOI] [Details] | |
| (2013) | 'A novel lipid-based solid dispersion for enhancing oral bioavailability of Lycopene - In vivo evaluation using a pig model' Faisal, W;Ruane-O'Hora, T;O'Driscoll, CM;Griffin, BT (2013) 'A novel lipid-based solid dispersion for enhancing oral bioavailability of Lycopene - In vivo evaluation using a pig model'. International Journal of Pharmaceutics, 453 :307-314 [DOI] [Details] | |
| (2013) | 'P-glycoprotein Inhibition Increases the Brain Distribution and Antidepressant-Like Activity of Escitalopram in Rodents' O'Brien, FE;O'Connor, RM;Clarke, G;Dinan, TG;Griffin, BT;Cryan, JF (2013) 'P-glycoprotein Inhibition Increases the Brain Distribution and Antidepressant-Like Activity of Escitalopram in Rodents'. Neuropsychopharmacology, 38 :2209-2219 [DOI] [Details] | |
| (2010) | 'Bioavailability of lycopene in the rat: the role of intestinal lymphatic transport' Faisal, W;O'Driscoll, CM;Griffin, BT (2010) 'Bioavailability of lycopene in the rat: the role of intestinal lymphatic transport'. Journal of Pharmacy and Pharmacology, 62 :323-331 [DOI] [Details] | |
| (2008) | 'Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8(+) T cells against Listeria monocytogenes in the murine infection model' Bahey-El-Din, M,Casey, PG,Griffin, BT,Gahan, CGM; (2008) 'Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8(+) T cells against Listeria monocytogenes in the murine infection model'. Vaccine, 26 :5304-5314 [DOI] [Details] | |
| (2006) | 'A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model' Griffin, BT,O'Driscoll, CM; (2006) 'A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model'. Journal of Pharmacy and Pharmacology, 58 :917-925 [DOI] [Details] | |
| (2018) | 'Application of the solubility parameter concept to assist with oral delivery of poorly water-soluble drugs - a PEARRL review' Jankovic, S. and Tsakiridou, G. and Ditzinger, F. and Koehl, N.J. and Price, D.J. and Ilie, A.-R. and Kalantzi, L. and Kimpe, K. and Holm, R. and Nair, A. and Griffin, B. and Saal, C. and Kuentz, M. (2018) 'Application of the solubility parameter concept to assist with oral delivery of poorly water-soluble drugs - a PEARRL review'. Journal of Pharmacy and Pharmacology, [DOI] [Details] | |
| (2018) | 'Drug-gut microbiota interactions: implications for neuropharmacology' Walsh, Jacinta; Griffin, Brendan T.; Clarke, Gerard; Hyland, Niall P. (2018) 'Drug-gut microbiota interactions: implications for neuropharmacology'. British journal of pharmacology, [DOI] [Full Text] [Details] | |
| (2018) | 'A dairy-derived ghrelinergic hydrolysate modulates food intake in vivo' Howick, K. and Wallace-Fitzsimons, S.E. and Kandil, D. and Chruscicka, B. and Calis, M. and Murphy, E. and Murray, B.A. and Fernandez, A. and Barry, K.M. and Kelly, P.M. and Ryan, A.M. and Cryan, J.F. and Griffin, B.T. and Schellekens, H. (2018) 'A dairy-derived ghrelinergic hydrolysate modulates food intake in vivo'. International Journal of Molecular Sciences, 19 (9) [DOI] [Details] | |
| (2018) | 'Microbiome-mediated bile acid modification: Role in intestinal drug absorption and metabolism' Enright, E.F. and Griffin, B.T. and Gahan, C.G.M. and Joyce, S.A. (2018) 'Microbiome-mediated bile acid modification: Role in intestinal drug absorption and metabolism'. Pharmacological Research, 133 :170-186 [DOI] [Details] | |
| (2018) | 'Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS): A rapid test for enteric coating thickness and integrity of controlled release pellet formulations' Alfarsi, A. and Dillon, A. and McSweeney, S. and Krüse, J. and Griffin, B. and Devine, K. and Sherry, P. and Henken, S. and Fitzpatrick, S. and Fitzpatrick, D. (2018) 'Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS): A rapid test for enteric coating thickness and integrity of controlled release pellet formulations'. International Journal of Pharmaceutics, 544 (1):31-38 [DOI] [Details] | |
| (2018) | 'Sustained-release multiparticulates for oral delivery of a novel peptidic ghrelin agonist: Formulation design and in vitro characterization' Howick, K. and Alam, R. and Chruscicka, B. and Kandil, D. and Fitzpatrick, D. and Ryan, A.M. and Cryan, J.F. and Schellekens, H. and Griffin, B.T. (2018) 'Sustained-release multiparticulates for oral delivery of a novel peptidic ghrelin agonist: Formulation design and in vitro characterization'. International Journal of Pharmaceutics, 536 (1):63-72 [DOI] [Details] | |
| (2018) | 'Regulation of biosimilar medicines and current perspectives on interchangeability and policy' O’Callaghan, John; Barry, Sean P.; Bermingham, Margaret; Morris, J. Michael; Griffin, Brendan T. (2018) 'Regulation of biosimilar medicines and current perspectives on interchangeability and policy'. European Journal of Clinical Pharmacology, [DOI] [Full Text] [Details] | |
| (2018) | 'Knowledge of Adverse Drug Reaction Reporting and the Pharmacovigilance of Biological Medicines: A Survey of Healthcare Professionals in Ireland' O'Callaghan J;Griffin BT;Morris JM;Bermingham M; (2018) 'Knowledge of Adverse Drug Reaction Reporting and the Pharmacovigilance of Biological Medicines: A Survey of Healthcare Professionals in Ireland'. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, [DOI] [Full Text] [Details] | |
| (2018) | 'Application of a Physiologically-Based Pharmacokinetic Model for the Prediction of Bumetanide Plasma and Brain Concentrations in the Neonate' Donovan, Maria D.; Abduljalil, Khaled; Cryan, John F.; Boylan, Geraldine B.; Griffin, Brendan T. (2018) 'Application of a Physiologically-Based Pharmacokinetic Model for the Prediction of Bumetanide Plasma and Brain Concentrations in the Neonate'. Biopharmaceutics & Drug Disposition, 39 :125-134 [DOI] [Full Text] [Details] | |
| (2018) | 'Exploring gastric emptying rate in mini-pigs: Effect of food type and pre-dosing of metoclopramide' Henze, Laura J.; Griffin, Brendan T.; Christiansen, Martin; Bundgaard, Christoffer; Langguth, Peter; Holm, Rene (2018) 'Exploring gastric emptying rate in mini-pigs: Effect of food type and pre-dosing of metoclopramide'. European Journal of Pharmaceutical Sciences, [DOI] [Full Text] [Details] | |
| (2018) | 'The pig as a pre-clinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms - a PEARRL review' Henze, Laura J.; Koehl, Niklas J.; O'Shea, Joseph P.; Kostewicz Edmund; Holm, Rene; Griffin, Brendan T. (2018) 'The pig as a pre-clinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms - a PEARRL review'. Journal of Pharmacy and Pharmacology, [DOI] [Full Text] [Details] | |
| (2017) | 'In vitro dissolutionmodels for the prediction of in vivo performance of an oral mesoporous silica formulation' McCarthy, CA;Faisal, W;O'Shea, JP;Murphy, C;Ahern, RJ;Ryan, KB;Griffin, BT;Crean, AM (2017) 'In vitro dissolutionmodels for the prediction of in vivo performance of an oral mesoporous silica formulation'. Journal Of Controlled Release, 250 :86-95 [DOI] [Details] | |
| (2017) | 'Assessing awareness and attitudes of healthcare professionals on the use of biosimilar medicines: A survey of physicians and pharmacists in Ireland' O'Callaghan, Joan; Bermingham, Margaret; Leonard, Maurice; Hallinan, Frank; Morris, J. Michael; Moore, Una; Griffin, Brendan T. (2017) 'Assessing awareness and attitudes of healthcare professionals on the use of biosimilar medicines: A survey of physicians and pharmacists in Ireland'. Regulatory toxicology and pharmacology : RTP, 88 :252-261 [DOI] [Full Text] [Details] | |
| (2017) | 'From Belly to Brain: Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation' Howick, Ken; Griffin, Brendan; Cryan, John; Schellekens, Harriët (2017) 'From Belly to Brain: Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation'. International Journal of Molecular Sciences, 18 (2) [DOI] [Full Text] [Details] | |
| (2017) | 'Impact of Gut Microbiota-Mediated Bile Acid Metabolism on the Solubilization Capacity of Bile Salt Micelles and Drug Solubility' Enright, EF;Joyce, SA;Gahan, CGM;Griffin, BT (2017) 'Impact of Gut Microbiota-Mediated Bile Acid Metabolism on the Solubilization Capacity of Bile Salt Micelles and Drug Solubility'. Molecular Pharmaceutics, 14 :1251-1263 [DOI] [Details] | |
| (2017) | 'Mesoporous silica based dosage forms improve bioavailability of poorly soluble drugs in pigs: case example fenofibrate' Joseph P. O’Shea, Kalpa Nagarsekar, Alena Wieber, Vanessa Witt3, Elisabeth Herbert, Caitriona M. O’Driscoll, Christoph Saal, Dieter Lubda, Brendan T. Griffin, Jennifer B. Dressman (2017) 'Mesoporous silica based dosage forms improve bioavailability of poorly soluble drugs in pigs: case example fenofibrate'. Journal of Pharmacy and Pharmacology, [DOI] [Details] | |
| (2016) | 'Lipid-based nanocarriers for oral peptide delivery' Niu, Z.,Conejos-Sánchez, I.,Griffin, Brendan T.,O’Driscoll, C.,Alonso, M. J. (2016) 'Lipid-based nanocarriers for oral peptide delivery'. Advanced Drug Delivery Reviews, [Details] | |
| (2016) | 'Regulatory Science Ireland: Bridging the information gap on biosimilar medicines' O'Callaghan, Joan; Barry, Sean; Moore, Una; Bermingham, Margaret; Morris, J. Michael; Hallinan, Frank; Griffin, Brendan T (2016) 'Regulatory Science Ireland: Bridging the information gap on biosimilar medicines'. Gabi Journal, 5 (4):168-170 [DOI] [Full Text] [Details] | |
| (2016) | 'Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo' Evans, J. C.,Malhotra, M.,Guo, J.,O'Shea, J. P.,Hanrahan, K.,O'Neill, A.,Landry, W. D.,Griffin, B. T.,Darcy, R.,Watson, R. W.,O'Driscoll, C. M. (2016) 'Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo'. Nanomedicine, 12 (8):2341-2351 [DOI] [Details] | |
| (2016) | 'Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs' Griffin, B. T.,Guo, J.,Presas, E.,Donovan, M. D.,Alonso, M. J.,O'Driscoll, C. M. (2016) 'Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs'. Advanced Drug Delivery Reviews, [DOI] [Details] | |
| (2016) | 'Lipid-based nanocarriers for oral peptide delivery' Niu Z;Conejos-Sánchez I;Griffin BT;O'Driscoll CM;Alonso MJ; (2016) 'Lipid-based nanocarriers for oral peptide delivery'. Advanced Drug Delivery Reviews, [DOI] [Details] | |
| (2016) | 'In vitro bidirectional permeability studies identify pharmacokinetic limitations of NKCC1 inhibitor bumetanide' Donovan, MD;Schellekens, H;Boylan, GB;Cryan, JE;Griffin, BT (2016) 'In vitro bidirectional permeability studies identify pharmacokinetic limitations of NKCC1 inhibitor bumetanide'. European Journal of Pharmacology, 770 :117-125 [DOI] [Details] | |
| (2016) | 'Treating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on antiepileptics' Donovan MD;Boylan GB;Murray DM;Cryan JF;Griffin BT; (2016) 'Treating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on antiepileptics'. British Journal of Clinical Pharmacology, 81 (1) [DOI] [Details] | |
| (2016) | 'Enhanced colonic delivery of ciclosporin A self-emulsifying drug delivery system encapsulated in coated minispheres' Keohane, K.,Rosa, M.,Coulter, I. S.,Griffin, B. T. (2016) 'Enhanced colonic delivery of ciclosporin A self-emulsifying drug delivery system encapsulated in coated minispheres'. Drug Development and Industrial PharmacyDrug Development and Industrial Pharmacy, 42 (22):245-253 [Details] | |
| (2014) | 'Biopharmaceutical Modeling of Drug Supersaturation During Lipid-Based Formulation Digestion Considering an Absorption Sink' Stillhart C, Imanidis G, Griffin BT, Kuentz M (2014) 'Biopharmaceutical Modeling of Drug Supersaturation During Lipid-Based Formulation Digestion Considering an Absorption Sink'. Pharmaceutical research, [DOI] [Details] | |
| (2014) | 'Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: Case studies with fenofibrate' Griffin, BT,Kuentz, M,Vertzoni, M,Kostewicz, ES,Fei, Y,Faisal, W,Stillhart, C,O'Driscoll, CM,Reppas, C,Dressman, JB (2014) 'Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: Case studies with fenofibrate'. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 86 :427-437 [DOI] [Details] | |
| (2013) | 'Human P-glycoprotein differentially affects antidepressant drug transport: relevance to blood-brain barrier permeability' O'Brien FE, Clarke G, Dinan TG, Cryan JF, Griffin BT (2013) 'Human P-glycoprotein differentially affects antidepressant drug transport: relevance to blood-brain barrier permeability'. International Journal of Neuropsychopharmacology, :1-14 [DOI] [Details] | |
| (2012) | 'Inhibition of P-glycoprotein Enhances Transport of the Antidepressant Imipramine across the Blood-Brain Barrier: Microdialysis Studies in the Conscious Freely Moving Rat' O'Brien FE, Clarke G, Fitzgerald P, Dinan TG, Griffin BT, Cryan JF (2012) 'Inhibition of P-glycoprotein Enhances Transport of the Antidepressant Imipramine across the Blood-Brain Barrier: Microdialysis Studies in the Conscious Freely Moving Rat'. British Journal of Pharmacology, [DOI] [Details] | |
| (2012) | 'Advances in lipid-based formulations: Overcoming the challenge of low bioavailability for poorly water soluble drug compounds' Griffin, BT (2012) 'Advances in lipid-based formulations: Overcoming the challenge of low bioavailability for poorly water soluble drug compounds'. American pharmaceutical review, 15 (2):41-47 [DOI] [Details] | |
| (2011) | 'Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: Clinical significance of in vitro and in vivo findings' O'Brien FE, Dinan TG, Griffin BT, Cryan JF; (2011) 'Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: Clinical significance of in vitro and in vivo findings'. British Journal of Pharmacology, [DOI] [Details] | |
| (2011) | 'Opportunities and challenges for oral delivery of hydrophobic versus hydrophilic peptide and protein-like drugs using lipid-based technologies' Griffin BT, O'Driscoll CM (2011) 'Opportunities and challenges for oral delivery of hydrophobic versus hydrophilic peptide and protein-like drugs using lipid-based technologies'. Therapeutic Delivery, 2 (12):1633-1653 [Details] | |
| (2010) | 'Efficacy of a Lactococcus lactis ΔpyrG vaccine delivery platform expressing chromosomally integrated hly from Listeria monocytogenes' Bahey-EL-Din, M; Caset, PG; Griffin, BT; Gahan, C; (2010) 'Efficacy of a Lactococcus lactis ΔpyrG vaccine delivery platform expressing chromosomally integrated hly from Listeria monocytogenes'. Bioengineered Bugs, 1 (1):66-74 [Details] | |
| (2010) | 'Expression of two Listeria monocytogenes antigens (P60 and LLO) in Lactococcus lactis and examination for use as live vaccine vectors' Bahey-EL-Din, M; Caset PG; Griffin, BT; Gahan, C; (2010) 'Expression of two Listeria monocytogenes antigens (P60 and LLO) in Lactococcus lactis and examination for use as live vaccine vectors'. Journal of Medical Microbiology, [DOI] [Details] | |
| (2010) | 'Lactococcus lactis as a cell factory for delivery of therapeutic proteins' Bahey-El-Din, M; Gahan, CG; Griffin, BT; (2010) 'Lactococcus lactis as a cell factory for delivery of therapeutic proteins'. Current Gene Therapy, 10 (1):34-45 [DOI] [Details] | |
| (2010) | 'A Methodology for Knowledge Management in Biopharmaceutical Production' Coakley, Jennifer; Hogan, Nicola; McGuire, Linda; Griffin, Brendan; Casey, Colman; Campbell, Cliff; Crean, Abina; (2010) 'A Methodology for Knowledge Management in Biopharmaceutical Production'. Pharmaceutical Engineering, 30 (3):30-40 [Details] | |
| (2008) | 'Nisin inducible production of listeriolysin O in Lactococcus lactis NZ9000' Bahey-El-Din M, Griffin BT, Gahan CG; (2008) 'Nisin inducible production of listeriolysin O in Lactococcus lactis NZ9000'. Microbial Cell Factories, 7 [DOI] [Full Text] [Details] | |
| (2008) | 'An examination of the effect of intestinal first pass extraction on intestinal lymphatic transport of saquinavir in the rat' Griffin BT, O'Driscoll CM; (2008) 'An examination of the effect of intestinal first pass extraction on intestinal lymphatic transport of saquinavir in the rat'. Pharmaceutical Research, 25 (5):1125-1133 [DOI] [Details] | |
| (2008) | 'Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations' O'Driscoll CM, Griffin BT; (2008) 'Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations'. Advanced Drug Delivery Reviews, 60 (6):617-624 [DOI] [Details] | |
| (2008) | 'Lactococcus Lactis-Expressing Listeriolysin O (Llo) Provides Protection and Specific Cd8(+) T Cells Against Listeria Monocytogenes In The Murine Infection Model' Bahey-El-Din, M, Casey, PG, Griffin, BT, Gahan, CGM; (2008) 'Lactococcus Lactis-Expressing Listeriolysin O (Llo) Provides Protection and Specific Cd8(+) T Cells Against Listeria Monocytogenes In The Murine Infection Model'. Vaccine, 26 (41):5304-5314 [DOI] [Details] |
Other Journals
| Year | Publication | |
|---|---|---|
| (2007) | 'Review of Endotoxins - Pyrogens, LAL testing and Depyrogenation' Griffin BT; (2007) 'Review of Endotoxins - Pyrogens, LAL testing and Depyrogenation' Informa Healthcare, . [Details] |
Book Chapters
| Year | Publication | |
|---|---|---|
| (2016) | ''Oral delivery of macromolecules – highlighting the challenges to maximize opportunities'' O'Mahony, A. M., Griffin, B. T., and O'Driscoll, C. M. (2016) ''Oral delivery of macromolecules – highlighting the challenges to maximize opportunities'' In: Advances and challenges in the oral delivery of macromolecules. Unitec House, 2 Albert Place, London, N3 1QB, UK: Future Science Ltd. [DOI] [Details] | |
| (2014) | 'Advances and challenges in the oral delivery of macromolecules' AM O'Mahony, BT Griffin and CM O'Driscoll (2014) 'Advances and challenges in the oral delivery of macromolecules' In: Greg Russell-Jones (eds). 1. Oral delivery of macromolecules – highlighting the challenges to maximize opportunities. London: Future Science Ltd. [Details] | |
| (2008) | 'Models of the small intestine' Griffin, Brendan and O’Driscoll, Caitriona (2008) 'Models of the small intestine' In: Springer. [Details] | |
| (2008) | 'Attack and counter-attack: targeted immunomodulation using bacterial virulence factors' Bahey-El-Din M, Griffin BT and CGM Gahan; (2008) 'Attack and counter-attack: targeted immunomodulation using bacterial virulence factors' In: Patho-Biotechnology. Austin: Landes BioSciences. [Details] |
Conference Publications
| Year | Publication | |
|---|---|---|
| (2011) | College of Medicine and Health Research Day (Brookfield, UCC, June 2011) O’Brien FE, Clarke G, Fitzgerald P, Griffin BT, Cryan JF (2011) An integrated microdialysis model for the analysis of blood-brain barrier drug transport in the conscious freely moving rat College of Medicine and Health Research Day (Brookfield, UCC, June 2011) [Details] | |
| (2010) | 2nd Conference on Innovation in Drug Delivery, International Society of Drug Delivery Sciences and Technology (APGI) Keohane, K., Brennan, D., Galvin, P., Griffin, B.T.; (2010) Microfluidics based approaches to preparation of biodegradable microparticles 2nd Conference on Innovation in Drug Delivery, International Society of Drug Delivery Sciences and Technology (APGI) [Details] | |
| (2008) | American Association of Pharmaceutical Scientists (AAPS) Faisal, W., O'Driscoll, C.M., Griffin, B.T.; (2008) Solubility and Stability of lycopene in lipid based formulations American Association of Pharmaceutical Scientists (AAPS) [Details] | |
| (2008) | UK & Ireland Controlled Release Society (UKICRS) Faisal, W., O'Driscoll, C.M., Griffin, B.T.; (2008) Investigation of Lycopene absorption mechanisms from the Gastro-intestinal tract of the rat UK & Ireland Controlled Release Society (UKICRS) [Details] | |
| (2007) | Excipient Fest Ireland Faisal W, O'Driscoll CM, Griffin BT; (2007) Comparison of the intestinal lymphatic transport of lycopene in anaesthetised rat Excipient Fest Ireland Cork, Ireland, , 19-JUN-07 - 20-JUN-07 [Details] | |
| (2007) | All Ireland School of Pharmacy Conference Faisal W, O'Driscoll CM, Griffin BT; (2007) Comparison of the intestinal lymphatic transport of lycopene in anaesthetised rat from a range of lipid based formulations All Ireland School of Pharmacy Conference Dublin, Ireland, [Details] | |
| (2004) | Amer Assoc Pharm Sci., (AAPS) Annual meeting Griffin BT, Lawless E and O¿Driscoll CM; (2004) Comparision of the degree of lymphatic transport of a range of lipophilic compounds in the presence of an oleic acid based microemulsion Amer Assoc Pharm Sci., (AAPS) Annual meeting Baltimore, USA, [Details] | |
| (2013) | Royal Academy of Medicine in Ireland (RAMI) Annual Meeting, University College Cork, June 2013 O’Brien FE, O’Connor RM, Clarke G, Dinan TG, Griffin BT, Cryan JF (2013) Effect of P-glycoprotein Inhibition on the brain distribution and antidepressant-like activity of escitalopram in rodents Royal Academy of Medicine in Ireland (RAMI) Annual Meeting, University College Cork, June 2013 [Details] | |
| (2012) | American Association of Pharmaceutical Scientists Annual Meeting and Exposition (AAPS) Chicago, USA, October 2012 O’Brien FE, Clarke G, Dinan TG, Cryan JF, Griffin BT (2012) P-glycoprotein limits antidepressant transport across the blood-brain barrier: converging evidence from in vitro and in vivo studies American Association of Pharmaceutical Scientists Annual Meeting and Exposition (AAPS) Chicago, USA, October 2012 [Details] | |
| (2012) | Neuroscience Ireland, RCSI, Dublin, September 2012 O’Brien FE, Clarke G, Dinan TG, Cryan JF, Griffin BT (2012) P-glycoprotein restricts blood-brain barrier transport of the antidepressant escitalopram: converging evidence from in vitro and in vivo studies Neuroscience Ireland, RCSI, Dublin, September 2012 [Details] | |
| (2012) | British Pharmacological Society (BPS) Winter Meeting, London, December 2012 O’Brien FE, Clarke G, Dinan TG, Cryan JF, Griffin BT (2012) The Influence of P-glycoprotein on the Blood-Brain Barrier Transport of the Antidepressant Escitalopram: Converging Evidence from In Vivo and In Vitro Studies British Pharmacological Society (BPS) Winter Meeting, London, December 2012 [Details] | |
| (2013) | 3rd Annual UK & Ireland Early Career BBB Symposium, Cambridge, UK, 22 November 2013 O’Brien FE, Clarke G, Dinan TG, Griffin BT, Cryan JF. (2013) P-glycoprotein inhibition as a strategy to augment antidepressant delivery across the blood-brain barrier: preclinical pharmacokinetic and pharmacodynamic studies 3rd Annual UK & Ireland Early Career BBB Symposium, Cambridge, UK, 22 November 2013 [Details] | |
| (2014) | 27th ECNP Congress Donovan, MD and O'Brien, FE and Boylan, GB and Griffin, BT and Cryan, JF (2014) An in vitro, in vivo, in silico approach to investigate effects of OAT3 inhibition on bumetanide levels in the brain 27th ECNP Congress Berlin, [Details] |
Editorship
| Year | Publication | |
|---|---|---|
| (2019) | The PEARRL reviews - innovative drug development strategies tailored to facilitate earlier access to new oral medicines. Griffin, BT;Dressman, JB (2019) The PEARRL reviews - innovative drug development strategies tailored to facilitate earlier access to new oral medicines. HOBOKEN: Editorship [DOI] [Details] |
Professional Activities
Honours and Awards
| Year | Title | Awarding Body | |
|---|---|---|---|
| 2007 | FMC BioPolymer Award | ExcipientFest Europe | |
| 1998 | Mendel Award | Pharmaceutical Technology Conference and Exhibition |
Professional Associations
| Association | Function | From / To | |
|---|---|---|---|
| Parenteral Drug Association | Comittee member of the Irish Chapter | 01-JAN-05 / 30-DEC-99 | |
| American association of Pharmaceutical Scientists | * | 01-JAN-98 / 30-DEC-99 |
Conference Contributions
| Year | Publication | |
|---|---|---|
| (2008) | The AAPS Annual Meeting, W. Faisal, C.M. O'Driscoll, B. Griffin ; (2008) Solubility and stability of lycopene in lipid-based formulations. [Oral Presentation], The AAPS Annual Meeting, Atlanta, USA , 15-NOV-08 - 15-NOV-08. [Details] | |
| (2007) | The 3rd Pharmaceutical Sciences World Congress PSWC, W. Faisal, C.M. O'Driscoll, B. Griffin; (2007) Investigations of the mechanisms of absorption of lycopene from the gastro-intestinal tract of the rat. [Oral Presentation], The 3rd Pharmaceutical Sciences World Congress PSWC, Amsterdam , 25-APR-07 - 25-APR-07. [Details] | |
| (2004) | Pharm Sci S 2172 Poster Presented at APPS, Griffin, B., Lawless, E. O¿Driscoll, C; (2004) Comparison of the Degree of Lymphatic Transport of a Range of Lipophilic Compounds in the Presence of an Oleic Acid-Based Microemulsion. [Oral Presentation], Pharm Sci S 2172 Poster Presented at APPS, USA , 01-NOV-04 - 01-NOV-04. [Details] |
Employment
| Employer | Position | From / To | |
|---|---|---|---|
| School of Pharmacy, UCC | Lecturer | 01-NOV-04 / | |
| University College Cork | Senior Lecturer | 02-NOV-14 / 02-DEC-14 | |
| School of Pharmacy, TCD | Lecturer (part-time) in MSc in Pharmaceutical Technology | 01-JAN-98 / 01-JAN-01 | |
| Servier Ireland Industries | Qualified Person (QP) Deputy Site QP | 01-JAN-02 / 29-OCT-04 | |
| Servier Ireland Industries | Industrial Pharmacist - Technical Services | 03-SEP-01 / 30-SEP-04 |
Education
| Year | Institution | Qualification | Subject | |
|---|---|---|---|---|
| 2001 | Trinity College Dublin | PHD | Pharmaceutics | |
| 1998 | Trinity College Dublin | Postgraduate Diploma | Quality control and Statistics | |
| 1996 | Trinity College Dublin | BSC | Pharmacy |
Consultancy
| Client | Description | |
|---|---|---|
Teaching Activities
Teaching Interests
Recent Postgraduates
| Graduation Year | Student Name | Institution | Degree Type | Thesis Title | |
|---|---|---|---|---|---|
| 2018 | Joseph O'Shea | University College Cork | DOCTOR OF PHILOSOPHY | Mechanistic understanding of bioenabling formulation approaches to improve oral bioavailability using porcine in vivo and in silico models | |
| 2016 | Maria Donovan | University College Cork | DOCTOR OF PHILOSOPHY | Novel Strategoies to Enhance Bumetanide Concentrations in teh Brain in the treatment of Neonatal Seizures | |
| 2014 | Kieran Keohane | University College Cork | PHD | DESIGN AND EVALUATION OF NOVEL MICROENCAPSULATION TECHNOLOGIES TO ENHANCE DELIVERY OF CICLOSPORIN | |
| 2009 | Mohammed Bahey El-din | University College Cork | PHD | Investigation of Lactococcus Lactis-based vaccines against Listeria monocytogenes | |
| 2014 | Fionn O'Brien | University College Cork | PHD | P-glycoprotein Inhibition as a Strategy to Increase Drug Delivery across the Blood-Brain Barrier: Focus on Antidepressants | |
| 2009 | Waleed Faisal | University College Cork | PhD | Lipid based formulation approaches to enhance bioavailability fo lycopene |
Research Information
External Collaborators
| Name | Organisation / Institute | Country | |
|---|---|---|---|
| Professor Jennifer Dressman | .W. Goethe University in Frankfurt | GERMANY | |
| Prof. Christos Reppas | National and Kapodestrian University of Athens | GREECE | |
| Professor Martin Kuentz | University of Applied Sciences North-western Switzerland | SWITZERLAND |
Contact details
- Brendan Griffin
Professor - brendan.griffin@ucc.ie
- Cavanagh Building
University College Cork
Cork - +353 21 4901657
- +353 21 4901656